In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company’s ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and…
Read More: https://www.fool.com/investing/2024/10/19/how-bad-is-this-news-for-novavax/?source=iedfolrf0000001
